COPD Trial, Recruiting NCT07522008 Sponsor: Azienda Ospedaliera Brotzu Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07522008
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older whose kidneys have failed completely and who are receiving regular dialysis treatment (the most advanced stage of chronic kidney disease).
  • People who have been on a stable, unchanged dialysis routine for at least 3 months before joining the trial.
  • People who have at least one moderate-to-severe symptom related to kidney failure, as identified by a standard symptom checklist completed at screening.
  • People whose treatment plan, as decided by their local medical team, includes a dialysis session combined with a special blood-filtering add-on therapy called hemoadsorption.
  • People who are able to read and sign a written consent form agreeing to take part.

Who may not be able to join:

  • People who have had a sudden illness, an active infection, or a hospital stay in the 4 weeks before joining the trial.
  • People who are expected to receive a kidney transplant during the period the trial is running.
  • People whose doctors estimate they have less than 6 months to live due to a serious health condition unrelated to their kidneys.
  • People who are not able to complete written questionnaires about their symptoms and wellbeing.
  • People who are already taking part in another clinical trial that could affect the results of this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claudio Ronco, MD, International Renal Research Institute of Vicenza

Phone: *393207718720

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliera Brotzu
Registry
ClinicalTrials.gov
Start date
15 March 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in uremic symptom burden

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov